Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phoenix Biotech Acquisition Corp

10.37
0.0000
Volume:- -
Turnover:- -
Market Cap:64.65M
PE:-42.14
High:10.37
Open:10.37
Low:10.37
Close:10.37
Loading ...
Apr 02, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Apr 02, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 22, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Feb 15, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Jan 18, 2024

Correspondence

Form CORRESP - Correspondence
Jan 08, 2024

Correspondence

Form CORRESP - Correspondence
Jan 05, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Correspondence

Form CORRESP - Correspondence
Dec 14, 2023

Correspondence

Form CORRESP - Correspondence
Dec 12, 2023

Correspondence

Form CORRESP - Correspondence
Dec 11, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 11, 2023

Major Issues Report

Form 8-K - Current report
Dec 07, 2023

Correspondence

Form CORRESP - Correspondence